Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Biocytogen and Whitehawk partner to develop ADCs | PharmaVoice

Pharma Tech

Biocytogen and Whitehawk partner to develop ADCs

Jul 8, 2026, 7:59 AM

Read Full Article → Biocytogen and Whitehawk partner to develop ADCs

Biocytogen and Whitehawk partner to develop ADCs

Translate article text

Choose a language and wait for the translated text.

Biocytogen and Whitehawk Therapeutics are set to develop bispecific antibody-drug conjugates (BsADCs), as part of a global partnership.